As of June 2023 Emergent BioSolutions has a market cap of $0.43 Billion. This makes Emergent BioSolutions the world's 5588th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.43 B | -26.96% |
2022 | $0.58 B | -74.81% |
2021 | $2.33 B | -50.75% |
2020 | $4.74 B | 70.25% |
2019 | $2.78 B | -8.1% |
2018 | $3.03 B | 30.9% |
2017 | $2.31 B | 74.34% |
2016 | $1.32 B | -15.65% |
2015 | $1.57 B | 53.55% |
2014 | $1.02 B | 21.95% |
2013 | $0.84 B | 46.34% |
2012 | $0.57 B | -4.97% |
2011 | $0.60 B | -26.29% |
2010 | $0.82 B | 96.03% |
2009 | $0.41 B | -46.37% |
2008 | $0.78 B | 418.97% |
2007 | $0.15 B | -51.12% |
2006 | $0.30 B |
On May 31st, 2023 the market cap of Emergent BioSolutions was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $214.63 B | 49,777.86% | ๐บ๐ธ USA |
![]() Merck MRK | $280.15 B | 65,004.66% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $69.32 B | 16,010.29% | ๐ฌ๐ง UK |
![]() Soligenix SNGX | $5.83 M | -98.64% | ๐บ๐ธ USA |
![]() SIGA Technologies SIGA | $0.39 B | -7.09% | ๐บ๐ธ USA |
![]() Celldex Therapeutics CLDX | $1.50 B | 249.19% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $8.30 B | 1,829.22% | ๐ฎ๐ฑ Israel |